Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.28
20.04.24
-
20.04.25
-0.23%
03.05.24

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.82
28.03.24
€5.55
28.03.25
-29.99%
03.05.24

Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.84
28.03.24
-
28.03.25
-30.67%
03.05.24

Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.12
27.03.24
-
27.03.25
-27.36%
30.03.24

Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.88
26.03.24
-
26.03.25
-18.09%
31.03.24

Risky Investment
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.00
23.03.24
€1.00
23.03.25
-36.15%
03.05.24

Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.87
21.03.24
-
21.03.25
-17.47%
31.03.24

Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.87
21.03.24
-
21.03.25
-31.56%
03.05.24

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.88
18.03.24
€6.00
18.03.25
-2.23%
28.03.24

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.73
18.03.24
-
18.03.25
-26.19%
03.05.24

Medium risks for its business
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
18.03.24
-
18.03.25
2.26%
30.03.24

Could be worthwhile Investment >10% per year
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
18.03.24
-
18.03.25
2.26%
28.03.24

Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
17.03.24
€0.30
30.11.25
76.96%
28.03.24

Could be very worthwhile Investment >20% year
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
16.03.24
€2.00
16.03.25
2.26%
30.03.24

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.92
29.11.23
€3.64
29.11.24
38.50%
03.05.24

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.92
17.11.23
€4.60
17.11.24
39.37%
03.05.24

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.11
27.09.23
€3.55
27.09.24
14.84%
03.05.24

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.27
28.08.23
€3.47
28.08.24
0.55%
03.05.24

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.92
31.05.23
-
31.05.24
38.35%
03.05.24

Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.44
23.05.23
-
23.05.24
-21.56%
25.05.23

Could be worthwhile Investment >10% per year
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.62
03.04.22
-
03.04.23
-37.48%
12.05.22

Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.20
25.03.22
-
25.03.23
-66.14%
30.03.22

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.32
21.03.22
-
21.03.23
-73.11%
03.04.22

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.44
18.04.21
€4.00
18.04.22
-12.30%
20.12.21

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.86
23.01.21
€3.00
23.01.22
-38.46%
24.01.22

Could be very worthwhile Investment >20% year
Higher risks for its business